Ctc LLC Novavax Inc Transaction History

Ctc LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 07, 2022	SELL	$36.28 - $75.29 $398,463 - $826,910	-10,983 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$69.73 - $142.9 $8.63 Million - $17.7 Million	-123,764 Reduced 91.85%	10,983 $808,000
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $5.92 Million - $9.59 Million	-44,006 Reduced 24.62%	134,747 $19.3 Million
Q3 2021 Oct 19, 2021	BUY	$177.8 - $270.58 $31.8 Million - $48.4 Million	178,753 New	178,753 $37.1 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Ctc LLC, based on Form 13F filings with the SEC.

Stay updated on Ctc LLC with notifications on news.